Enhanced Clopidogrel Response in Smokers is Reversed After Discontinuation as Assessed by VerifyNow Assay : 흡연 시와 금연 후의 클로피도그렐의 항혈소판 반응성의 변화

DC Field Value Language
dc.description학위논문 (석사)-- 서울대학교 대학원 : 협동과정 임상약리학전공, 2014. 2. 김효수.-
dc.description.abstractIntroduction: Previous reports on smokers paradox to clopidogrel have only been able to show an association between cigarette smoking and enhanced response to clopidogrel therapy. No study has shown reversal of enhanced clopidogrel response after smoking cessation. We conducted a prospective observational longitudinal study to measure the impact of cigarette smoking on on-clopidogrel platelet reactivity (OPR).
Methods: From the prospective CROSS-VERIFY cohort, 810 subjects with repeated measurement of OPR at least 1 month apart were analyzed. With smoking status ascertained at 2 time points, baseline and follow-up, study subjects were categorized into never smokers (n=628), smoking quitters (n=77), and persistent smokers (n=105). Dependent variables included OPR measured by the VerifyNowTM assay and the percentage of subjects with high OPR (HOPR).
Results: At baseline, current smokers showed significantly lower OPR compared with never smokers, with no significant differences in OPR between future quitters and future persistent smokers within current smokers. While the OPR of never smokers and persistent smokers did not change significantly during the follow-up, the mean OPR of quitters increased significantly by 19 P2Y12 reaction units (p=0.013). The frequency of HOPR showed similar results with an 8-10% increase in smoking quitters in contrast to no significant changes in never and persistent smokers. Both mean OPR and the frequency of HOPR showed a linear inverse relationship with the amount of smoking.
Conclusions: Enhanced clopidogrel response in smokers is reversed after smoking discontinuation, suggesting causal relationship in addition to previously reported association between smoking and enhanced clopidogrel response.
dc.description.tableofcontentsi. Introduction
ii. Materials and Methods
iii. Results
iv. Discussion
v. Conclusion

List of tables
Table 1. Baseline characteristics
Table 2. Comparison of on-clopidogrel platelet reactivity (OPR)* according to smoking status at two different time points
Table 3. The rates of patients with high on-treatment platelet reactivity (HOPR)* according to smoking status at two different time points

List of figures
Figure 1. Study scheme
Figure 2. Distribution of platelet reactivity units (PRU)
Figure 3. Comparison of platelet reactivity units (PRU)
Figure 4. Multivariable-adjusted analyses with regard to platelet reactivity unit (PRU)
Figure 5. Relationship between smoking amount and the response to clopidogrel therapy
dc.format.extent1053509 bytes-
dc.publisher서울대학교 대학원-
dc.subjectantiplatelet agent-
dc.titleEnhanced Clopidogrel Response in Smokers is Reversed After Discontinuation as Assessed by VerifyNow Assay-
dc.title.alternative흡연 시와 금연 후의 클로피도그렐의 항혈소판 반응성의 변화-
dc.contributor.AlternativeAuthorSi Hyuk Kang-
dc.citation.pagesii, 22-
dc.contributor.affiliation의과대학 협동과정임상약리학전공-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Program in Clinical Pharmacology (협동과정-임상약리학전공)Theses (Master's Degree_협동과정-임상약리학전공)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.